Wavelength Pharmaceuticals

Developer and manufacturer of generic active pharmaceutical ingredients (API) and finished dose forms (FDF).

Health Tech & Life Sciences
Acquired by SK Capital
Acquired Petah Tikva, Israel Founded 1987
Last updated 2026-07-26
Total raised
Last: Undisclosed Round 2022-07
Stage
Acquired
Founded
1987
Headcount
125
HQ
Petah Tikva, Israel
Sector
Health Tech & Life Sciences

About

Wavelength Pharmaceuticals is an Israeli company that develops and manufactures active pharmaceutical ingredients (API) and finished dose forms (FDF). The company focuses on differentiated products requiring sophisticated manufacturing processes and offers comprehensive technical and regulatory support. Their core strengths include complex chemistry, innovative process development, crystalline forms, and particle design. They also provide a full spectrum of API CDMO (Contract Development and Manufacturing Organization) services, from preclinical grams to multi-ton commercial quantities. Wavelength Pharmaceuticals was formerly known as Chemagis and Perrigo API.

Funding history · 1 round · — total

2022-06
Grant Undisclosed

Headcount over time

From 54 (2019-09) to 95 (2024-01) · +41 (+76%) · 6 points · source: Finder history + radar grounding
1100 2019-09 2024-01

Q&A

What is Wavelength Pharmaceuticals' primary business?
Wavelength Pharmaceuticals develops and manufactures active pharmaceutical ingredients (APIs) and select finished dosage forms, focusing on differentiated products requiring sophisticated manufacturing processes.
When was Wavelength Pharmaceuticals founded?
Wavelength Pharmaceuticals was founded in January 1987.
What is the current employee count for Wavelength Pharmaceuticals?
Wavelength Pharmaceuticals has 51-200 employees.
When was Wavelength Pharmaceuticals acquired and by whom?
Wavelength Pharmaceuticals was acquired by SEQENS in December 2021.
What was a significant financial event for Wavelength Pharmaceuticals in 2017?
In November 2017, Wavelength Pharmaceuticals was acquired by SK Capital Partners for $110,000,000.
What was the most recent funding round for Wavelength Pharmaceuticals?
The most recent funding round for Wavelength Pharmaceuticals was a grant in July 2022.
Does Wavelength Pharmaceuticals hold any patents?
Yes, Wavelength Pharmaceuticals holds one patent.
Where are Wavelength Pharmaceuticals' offices located?
Wavelength Pharmaceuticals has offices in Ramat Hovav and Petah Tikva, Israel; Barcelona, Spain; and Wayne, USA.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Materials & SubstancesBiologicals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B

Highlights

1 Patents

Tags

pharmaceuticalsapiallergysleep-disordersgastroenterologyalzheimers-diseasesupply-chainrespiratorycancerdermatology
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitewavelengthpharma.com
LinkedInlinkedin.com/company/35473024
Facebookfacebook.com/wavelengthpharma
YouTubeyoutube.com/@wavelengthpharma5837

Identifiers & details

Former namesChemagis, Perrigo API, Perrigo
Founded1987-1
Employees (exact)125
OfficesBarcelona; Wayne; Petah Tikva
Status reasonAcquired by SK Capital Partners on Nov, 2017

Acquisitions & public offerings

Acquired by SK Capital 2017-11 $110.0M

AcquiredDateAmount
Vanamali Organics2021-02
TypeDateExchangeTickerAmount
2021-12
2017-11$110.0M

Radar intelligence

Web history (Wayback)

Domainwavelengthpharma.com

Certificate / subdomain footprint

Subdomains4

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)515666485
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2017-05-29
Purposeלעסוק בכל עיסוק חוקי
Liabilityמוגבלת
In violation (unfiled)no
Last annual report2025
Active charges / liens0
Registry events3 — people (3)
Registered addressלח~י 29 בני ברק

Recent registry events

DateEvent
2026-05-11עדכון בעלי תפקידים
2026-05-06עדכון דירקטורים-הוספת דירקטור
2026-05-06עדכון דירקטורים-הסרת דירקטור